Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Positive opinions for 15 new medicines

Country: United Kingdom

The European Medicines Agency has given positive opinions for 15 new medicines including treatments for hepatitis C infection, Cushing’s syndrome and for non-small cell lung and gastric cancers. The decisions were announced on 26 September.

Read more

Adaptimmune raises $104 million

Country: United Kingdom

Adaptimmune Ltd, which is developing a T cell therapies for cancer and infectious disease, has raised $104 million in a Series A financing round to support its ongoing work in multiple cancer indications. The oversubscribed round was led by New Enterprise Associates of the US.

Read more

Probiodrug to launch IPO in Amsterdam

Country: Germany

Read more

Nicox glaucoma drug meets trial endpoint

Country: France

Read more

Shire to pay $56.5 million US fine

Country: United States

Read more

Regeneron to appeal against patent decision

Country: United States

Read more

Merck KGaA to buy Sigma-Aldrich

Country: Germany

Read more

CureVac to work with BI in lung cancer

Country: Germany

Read more

Kymab succeeds in patent challenge

Country: United Kingdom

Read more

GSK’s China entity ordered to pay fine

Country: United Kingdom

Read more

Evotec to sue Andromeda

Country: Germany

Read more

Bayer to float its materials science business

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

How Britain champions medical innovation

UKasBiocentreSept2014.pdf

Highlights of the September 2014 MedNous issue

The September 2014 MedNous features:

Latest Mednous cover
  • Financial Strategy
    How Versant Ventures
    builds to buy
  • Research Strategy
    New targets for
    malaria vaccines
  • Public Policy
    Britain champions
    medical innovation
  • Commentary
    Getting traction against
    antimicrobial resistance
    By Dawn Firmin
  • Commentary
    Expanding medicine access
    through formulation
    By Thomas Reese Saylor

The latest MedNous journal. Subscribe to download.

Recent Appointments